19 Hrs
Source:
الوئام
_1777294237270_124456903.png&w=64&q=75){kind=small}
Source: الوئام
19 Hrsالوئام
Source: الوئام
19 HrsReady to play
Ready to play
Russia’s Gamaleya Research Center is developing artificial intelligence programs to predict precancerous changes and detect their early markers, including neoantigens, according to its director, Denis Logunov. The tool can distinguish cells with up to 99.9% accuracy by analyzing RNA sequences and assessing their protein composition, but training it requires a large database.
Notice: This Is an AI-Generated Summary
Comments (0)